Clin Res Cardiol (2023). https://doi.org/10.1007/s00392-023-02180-w |
||
Pulsed-field ablation in patients with cardiac implantable electronic devices: Is it safe? | ||
M. Kottmaier1, T. Reents1, F. Bourier1, M.-A. Popa2, F. Bahlke1, N. Erhard1, F. Englert2, S. Lengauer1, C. Schaarschmidt1, G. Heßling2, C. Kolb1, I. Deisenhofer2, C. Lennerz1 | ||
1Klinik für Herz- und Kreislauferkrankungen, Deutsches Herzzentrum München, München; 2Elektrophysiologie, Deutsches Herzzentrum München, München; | ||
Aims: Methods: PFA lesions (45 per CIED) were applied from the Farapulse system to CIEDs (<5cm from the lead tip and <15cm from the generator). All devices were checked before and after PFA application for proper sensing- and pacing-functionality as well as for integrity of shock circuits in ICDs using a heart simulator. Moreover, devices were then interrogated for any spontaneous reprogramming, mode switching or other EMI effects. Results: Conclusions: |
||
https://dgk.org/kongress_programme/jt2023/aP1282.html |